Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tindupepimut by Enterome Bioscience for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
Tindupepimut is under clinical development by Enterome Bioscience and currently in Phase II for Recurrent Glioblastoma Multiforme (GBM). According to...